Syros to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
August 01 2023 - 7:30AM
Business Wire
Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company
committed to advancing new standards of care for the frontline
treatment of hematologic malignancies, today announced that it will
host a live conference call and webcast at 8:30 a.m. ET on Tuesday,
August 8, 2023 to report its second quarter 2023 financial results
and provide a corporate update.
To access the live conference call, please dial (888) 886-7786
(domestic) or (416) 764-8658 (international) and refer to
conference ID 25163081. A webcast of the call will also be
available on the Investors & Media section of the Syros website
at www.syros.com. An archived replay of the webcast will be
available for approximately 30 days following the call.
About Syros Pharmaceuticals
Syros is committed to developing new standards of care for the
frontline treatment of patients with hematologic malignancies.
Driven by the motivation to help patients with blood disorders that
have largely eluded other targeted approaches, Syros is advancing a
robust late-stage clinical pipeline, including tamibarotene, an
oral selective RARα agonist in patients with higher-risk
myelodysplastic syndrome and acute myeloid leukemia with RARA gene
overexpression, and SY-2101, a novel oral form of arsenic trioxide
in patients with acute promyelocytic leukemia. Syros is also
seeking out-licensing opportunities for SY-5609, a highly selective
and potent clinical-stage CDK7 inhibitor for the treatment of
select solid tumors, and for multiple preclinical programs in
oncology. For more information, visit www.syros.com and follow us
on Twitter (@SyrosPharma) and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230801164906/en/
Syros Karen Hunady Director of Corporate Communications
& Investor Relations 1-857-327-7321 khunady@syros.com
Investors Hannah Deresiewicz Stern Investor Relations,
Inc. 212-362-1200 hannah.deresiewicz@sternir.com
Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Apr 2024 to May 2024
Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From May 2023 to May 2024